Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:835-838
Published online before print February 14, 2005, doi: 10.1161/01.CIR.0000155617.54749.09
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
111/7/835    most recent
01.CIR.0000155617.54749.09v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zitron, E.
Right arrow Articles by Karle, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zitron, E.
Right arrow Articles by Karle, C. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Cardiovascular Pharmacology
Right arrow Primary prevention
Right arrow Arrythmias-basic studies
Right arrowRelated Article

(Circulation. 2005;111:835-838.)
© 2005 American Heart Association, Inc.


Arrhythmia/Electrophysiology

QTc Prolongation by Grapefruit Juice and Its Potential Pharmacological Basis

HERG Channel Blockade by Flavonoids

Edgar Zitron, MD*; Eberhard Scholz, BSc*; Robert W. Owen, PhD; Sonja Lück, BSc; Claudia Kiesecker, MSc; Dierk Thomas, MD; Sven Kathöfer, MD; Feraydoon Niroomand, MD; Johann Kiehn, MD; Volker A.W. Kreye, MD; Hugo A. Katus, MD; Wolfgang Schoels, MD; Christoph A. Karle, MD

From the Departments of Cardiology (E.Z., E.S., S.L., C.K., D.T., S.K., F.N., J.K., H.A.K., W.S., C.A.K.) and Physiology and Pathophysiology (V.A.W.K.), University of Heidelberg Medical School, and Division of Toxicology and Cancer Risk Factors (R.W.O.), German Cancer Research Center, Heidelberg, Germany.

Correspondence to Dr. Christoph A. Karle, Medical University Hospital Heidelberg, Department of Cardiology, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany. E-mail Christoph1_karle{at}med.uni-heidelberg.de

Received May 22, 2004; revision received November 10, 2004; accepted November 17, 2004.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background— A high intake of dietary flavonoids, which are abundant in fruits, vegetables, tea, and wine, is known to reduce cardiovascular mortality. The effects of flavonoids on cardiac electrophysiology, which theoretically may have both antiarrhythmic and proarrhythmic consequences, have not been studied systematically to date.

Methods and Results— We screened a broad spectrum of flavonoids for their inhibitory activity on HERG channels by using heterologous expression in Xenopus oocytes. At a concentration of 1 mmol/L, 10 compounds caused a significant inhibition of HERG currents, whereas 11 other flavonoids had no effect. The IC50 value for HERG block by naringenin, the most potent inhibitor, was 102.3 µmol/L in Xenopus oocytes and 36.5 µmol/L in HEK cells. To demonstrate the physiological relevance of these findings, we studied the effects of pink grapefruit juice, which contains large amounts of naringenin glycosides (>1000 µmol/L), in human volunteers. In 10 persons, we observed a peak QTc prolongation of 12.5±4.2 ms 5 hours after oral ingestion of 1 L of grapefruit juice. This effect was significant (P=0.02).

Conclusions— We found a significant QTc prolongation by grapefruit juice in healthy volunteers, probably caused by block of HERG channels by flavonoids. These findings reveal new perspectives on the potential for dietary modification of cardiac electrophysiology.


Key Words: antiarrhythmia agents • arrhythmia • ion channels • nutrition • pharmacology


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Flavonoids are a class of natural polyphenolics (Figure 1A) that are ubiquitous in plants, vegetables, fruits, and beverages of plant origin, such as tea and wine.1 Numerous prospective epidemiological studies have found beneficial effects of flavonoid consumption on overall cardiovascular mortality,2–7 and flavonoid consumption repeatedly has been suggested to play a major role in the "French paradox."8 Flavonoids apparently reduce the incidence of fatal complications associated with acute myocardial infarction and the postinfarction period.7



View larger version (56K):
[in this window]
[in a new window]
 
Figure 1. A, Chemical structure of flavonoids. B, Blockade of HERG channels by a broad range of flavonoids. Relative HERG currents are shown for all flavonoids tested (n=6 each). Significant difference from vehicle controls (DMSO, left column) is indicated by a darker color. C, Dose-response relation of selected flavonoids. Typical HERG current traces measured in Xenopus oocytes are displayed from experiments with naringenin (C-C), morin (C-D), and hesperetin (C-E). Dose-effect curves in Xenopus oocytes yielded IC50 values of 102.3, 111.4, and 288.8 µmol/L, respectively (C-A, n=6 each). In HEK cells, naringenin had an IC50 value of 36.5 µmol/L and caused a mild inhibition even at a concentration of 1 µmol/L (C-B, n=5).

Conventionally, these beneficial effects have been attributed primarily to nonspecific antioxidant and antithrombotic properties of flavonoids6; however, major fatal complications of acute and chronic myocardial infarctions are malignant ventricular arrhythmias.9 Therefore, we examined the effects of dietary flavonoids on cardiac electrophysiology in vitro and in vivo.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Subjects
Ten volunteers (5 women and 5 men) participated in the ECG study. Subject characteristics were age, 25.2±4.6 years (mean±SD) (range, 20 to 37 years); weight, 70.5±10.4 kg (range, 59 to 92 kg); and body mass index, 23.4±3.4 kg/m2 (range, 18.6 to 29.7 kg/m2). The subjects were all healthy, with no history of disease of the cardiovascular system or the gastrointestinal tract. None of the subjects were taking any medications. All participants provided informed consent. The Ethics Committee of the University of Heidelberg approved the study design.

Study Design
The participants drank 1 L of freshly squeezed pink grapefruit juice within half an hour in the morning. Continuous 12-channel Holter ECG recording was started 30 minutes beforehand and continued for 12 hours afterward. To examine diurnal variation of QTc duration, a second Holter ECG recording was performed in all participants on a day during which they refrained from drinking citrus juice and tea.

Holter ECG Recording and Analysis
ECGs were recorded with continuous 12-channel Holter ECG recording and evaluated with Mortara Research Tool Software (Mortara Instrument). According to common practice, short periods with electric artifacts were excluded from analysis by use of H-Scribe Software (Mortara). Leads V4 and V6 were selected for automatic analysis because T-wave signals were optimal in those leads. Measurement of RR and QT values was performed automatically, without any manual correction. QTc values were generated automatically by use of Bazett’s formula. QTc values of all heartbeats for a period of 5 minutes were averaged to obtain a mean value. Six of those were averaged to determine mean QTc values for periods of 30 minutes. Synchronized data from all ECGs were fitted with a polynomial regression curve by use of Origin 4.0 software (Microcal Inc) to obtain a graphical fit (Figure 2).



View larger version (36K):
[in this window]
[in a new window]
 
Figure 2. Transient QTc prolongation after ingestion of grapefruit juice. Time course of mean QTc prolongation measured in 10 persons after ingestion of grapefruit juice is displayed in front of a background (shaded) showing schematic plasma kinetics of naringenin after single-dose oral ingestion of grapefruit juice as described by Erlund et al12 in arbitrary units. Second curve, synchronized to other ECG data, demonstrates mean QTc shortening in same subjects as observed under control conditions as a consequence of diurnal variation of QTc duration. Asterisks indicate a significant difference from control ECGs and from baseline recordings.

Molecular Biology and Electrophysiology
The HERG cDNA (GenBank accession No. hs04270) was a gift from Dr M.T. Keating (Salt Lake City, Utah). Heterologous expression in Xenopus oocytes was performed as described previously.10 The double-electrode voltage-clamp configuration was used as described previously.10 This investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication No. 85-23, revised 1996).

Solutions and Drug Administration
All substances were purchased from Sigma. Flavonoids were dissolved in DMSO to prepare stock solutions (100 mmol/L) and stored at –20°C.

Data Analysis
Dose-effect curves were fitted with the Hill equation as described previously.10 Statistical data are expressed as mean±SEM, with n representing the number of experiments performed. Statistical significance was evaluated by use of the unpaired Student t test (electrophysiological experiments and comparison of ECGs after ingestion of grapefruit juice with control ECGs) and the paired Student t test (comparison of ECGs before and after ingestion of grapefruit juice).


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
We screened a large number of flavonoids for their inhibitory activity to HERG channels, the molecular correlate of the rapid delayed rectifier potassium current IKr,11 which may provide a basis of potential antiarrhythmic effects. We selected major compounds within different structural flavonoid subgroups to cover a broad spectrum: flavanone glycosides (neohesperidin, hesperidin, naringin), flavanone aglycones (galangin, hesperetin, naringenin), flavone glycosides (rutin), flavone aglycones (flavone, chrysin, fisetin, kaempferol, morin, quercetin, myricetin, apigenin), furanocoumarin derivatives (bergapten, methoxsalen, psoralen), and coumarin derivatives (scopoletin, umbelliferone, coumarin, 7-ethoxycoumarin) (Figure 1B).

In Xenopus oocytes heterologously expressing the channels, typical HERG currents were recorded with a standard protocol. From a holding potential of –80 mV, a first test pulse to +30 mV (400 ms) evoked activating currents, and a return pulse to –60 mV (400 ms) elicited large outward tail currents characteristic of HERG channels. Flavonoids were washed into the bath at a concentration of 1 mmol/L, and the test pulse protocol was repeated at a frequency of 0.07 Hz for 15 minutes. Peak tail currents of the recordings at the beginning and end of the perfusion were compared to quantify the amount of block.

Six experiments were performed with each flavonoid and compared with vehicle controls with DMSO at a concentration of 1% (vol/vol) (n=6). Ten compounds caused a significant inhibition of HERG currents: naringenin, hesperetin, morin, flavone, kaempferol, quercetin, methoxsalen, scopoletin, umbelliferone, and 7-ethoxycoumarin (Figure 1B).

In the screening experiments, naringenin, morin, and hesperetin exhibited the highest potency of HERG channel blockade. Dose-effect relations of these compounds measured in the Xenopus oocyte expression system yielded IC50 values of 102.3 µmol/L for naringenin, 111.4 µmol/L for morin, and 288.8 µmol/L for hesperetin (n=6 each) (Figure 1C). In HEK cells, the IC50 for naringenin was 36.5 µmol/L (n=5) (Figure 1C). At a concentration of 1 µmol/L, naringenin exerted a mild inhibitory effect, reducing HERG currents by 13.8±2.4% (n=5).

The glycosides of naringenin are the major flavonoid components in pink grapefruit juice (>1000 µmol/L).12 Given our findings of HERG blockade by naringenin, we examined whether grapefruit juice can mimic the effects of class III antiarrhythmic drugs, ie, induce QT prolongation.

Ten healthy volunteers drank 1 L of freshly squeezed pink grapefruit juice in the morning. Software analysis of Holter ECG recordings revealed a transient QTc prolongation in the ensuing hours (Figure 2). Mean QTc prolongation 4 and 5 hours after ingestion of the grapefruit juice was 10.6±2.8 and 12.5±4.2 ms, respectively (n=10). The difference from the initial recordings, ie, before drinking the juice, was highly significant (P=0.004 and P=0.024, respectively). Using Fridericia’s formula for heart rate correction instead of Bazett’s formula, peak QTc prolongation is 10.3±3.0 ms (t=5 hours, P=0.01). QTc prolongation declined again and approached baseline values (3.0±2.2 ms) 9 hours after ingestion of the juice. Other relevant surface ECG parameters were not affected (data not shown).

Diurnal variation of QTc duration has been described in healthy persons, with a decrease during daytime and an increase at night.13,14 We verified these previously published observations in the participating individuals by performing a second continuous ECG recording on a day during which they refrained from drinking citrus juice and tea (Figure 2). At the time corresponding to the observed QTc prolongation after ingestion of grapefruit juice, we found a mean QTc shortening of –8.0±3.0 ms (t=4 hours) and –5.9±6.0 ms (t=5 hours), respectively (n=10). This was significantly different from the effects of grapefruit juice (P=0.002 and P=0.024, respectively).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
To the best of our knowledge, we are the first to show direct effects on the ECG by dietary compounds. Furthermore, we have demonstrated for the first time that flavonoids act as specific antagonists of cardiac potassium channels.

The concentration used in the screening experiments was relatively high because we had to take into account the fact that higher drug concentrations are needed in Xenopus oocytes.15,16 We intended primarily to collect qualitative data, because for many flavonoids, quantitative data on bioavailability and resulting plasma concentrations are not yet available.17 Therefore, it is currently not possible to estimate the significance of these compounds. Naringenin is well characterized in terms of bioavailability, which enabled us to demonstrate the physiological relevance of our findings. Other important flavonoids (particularly hesperetin, quercetin, and kaempferol, all of which reach plasma concentrations of 0.7 to 2 µmol/L)17 also exhibited inhibitory effects on HERG channels, although with lower potency. Furthermore, it is remarkable that more than half of the flavonoids tested showed HERG activity, which suggests that there may be numerous other flavonoids with similar properties.

At a concentration of 1 µmol/L, naringenin reduced HERG currents in HEK cells by {approx}14%. Naringenin is one of the most important flavonoids in grapefruit, with a concentration of >1000 µmol/L in juice.12 Plasma kinetics of naringenin18 are remarkably congruent with the time course of QTc prolongation observed in our study (Figure 2, background). The bioavailability of grapefruit-derived naringenin is high. According to the literature, plasma levels reach concentrations of 6.0 µmol/L, with a peak after 4 to 6 hours.18

Taking the HEK cell experiments into account, it seems likely that mild HERG inhibition already occurs at these concentrations. Because the mild QTc prolongation of 10 to 12 ms measured in the ECG study probably corresponds to a merely partial HERG blockade, the observed effect is probably attributable primarily to naringenin. The variety of grapefruit flavonoids with HERG activity may also elicit cumulative effects, however.

It has been found that QTc duration varies diurnally in healthy persons, with a maximum at night and a steady decline during the morning and afternoon, followed by an increase in the evening.13,14 In our study, grapefruit juice was ingested in the morning, and transient QTc prolongation was observed in the ensuing 6 to 8 hours. With regard to the normal diurnal variation, one would have expected a decrease in QTc duration instead. Indeed, control recordings showed a shortening of the QTc interval in the corresponding period in the same persons. Therefore, our data provide strong evidence that grapefruit juice has direct effects on cardiac repolarization.

In summary, we have found numerous different flavonoid compounds in grapefruit juice that block cardiac HERG channels and may cause a prolongation of the QTc interval as a consequence. These findings provide a rational basis for potential effects of flavonoids on cardiac electrophysiology. From a theoretical point of view, HERG channel blockade may have antiarrhythmic or proarrhythmic effects.19 Taking the positive epidemiological data into account, however, proarrhythmic properties of flavonoids appear unlikely.

On the basis of this "proof of principle," we wish to encourage further research in this field, which may result in new dietary recommendations for patients at risk of cardiovascular events. Flavonoids may also prove to be a promising new class of antiarrhythmic agents, combining electrophysiological effects with antioxidant and antithrombotic properties.


*    Acknowledgments
 
This work was supported by grants from the Deutsche Forschungsgemeinschaft, Ki 663/1-1 to Dr Kiehn and Ka 1714/1-1 to Dr Karle, and from the Deutsche Stiftung für Herzforschung to Dr Thomas. Dr Owen is grateful to the Verein zur Förderung der Krebsforschung in Deutschland eV for funding. The excellent technical assistance of Klara Gueth, Ramona Bloehs, and Patrizia Kraft and the expert support of T. Hilbel and J. Laude concerning software design for the analysis of Holter ECG data are gratefully acknowledged. The authors thank their friends and colleagues for participating in this study.


*    Footnotes
 
*The first 2 authors contributed equally to this work. Back


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 

  1. Mattila P, Astola J, Kumpulainen J. Determination of flavonoids in plant material by HPLC with diode-array and electro-array detections. J Agric Food Chem. 2000; 48: 5834–5841.[CrossRef][Medline] [Order article via Infotrieve]
  2. Hertog MG, Feskens EJ, Hollmann PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 1993; 342: 1007–1011.[CrossRef][Medline] [Order article via Infotrieve]
  3. Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ. 1996; 312: 478–481.[Abstract/Free Full Text]
  4. Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willet WC. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med. 1996; 125: 384–389.[Abstract/Free Full Text]
  5. Yochum L, Kushi LH, Meyer K, Folsom AR. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol. 1999; 149: 943–949.[Abstract/Free Full Text]
  6. Geleijnse JM, Launer LJ, Van der Kuip DA, Hofman A, Witteman JC. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr. 2002; 75: 880–886.[Abstract/Free Full Text]
  7. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Tea consumption and mortality after acute myocardial infarction. Circulation. 2002; 105: 2476–2481.[Abstract/Free Full Text]
  8. de Lorgeril M, Salen P, Paillard F, Laporte F, Boucher F, de Leiris J. Mediterranean diet and the French paradox: two distinct biogeographic concepts for one consolidated scientific theory on the role of nutrition in coronary heart disease. Cardiovasc Res. 2002; 54: 503–515.[Free Full Text]
  9. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med. 2001; 345: 1473–1482.[Free Full Text]
  10. Zitron E, Karle CA, Wendt-Nordahl G, Kathofer S, Zhang W, Thomas D, Weretka S, Kiehn J. Bertosamil blocks HERG potassium channels in their open and inactivated states. Br J Pharmacol. 2002; 137: 221–228.[CrossRef][Medline] [Order article via Infotrieve]
  11. Ackerman MJ, Clapham DE. Ion channels: basic science and clinical disease. N Engl J Med. 1997; 336: 1575–1586.[Free Full Text]
  12. Ameer B, Weintraub RA, Johnson JV, Yost RA, Rouseff RL. Flavanone absorption after naringin, hesperidin, and citrus administration. Clin Pharmacol Ther. 1996; 60: 34–40.[CrossRef][Medline] [Order article via Infotrieve]
  13. Antimisiaris M, Sarma JS, Schoenbaum MP, Sharma PP, Venkataraman K, Singh BN. Effects of amiodarone on the circadian rhythm and power spectral changes of heart rate and QT interval: significance for the control of sudden death. Am Heart J. 1994; 128: 884–891.[CrossRef][Medline] [Order article via Infotrieve]
  14. Yi G, Guo XH, Reardon M, Gallagher MM, Hnatkova K, Camm AJ, Malik M. Circadian variation of the QT interval in patients with sudden cardiac death after myocardial infarction. Am J Cardiol. 1998; 81: 950–956.[CrossRef][Medline] [Order article via Infotrieve]
  15. Witchel HJ, Milnes JT, Mitcheson JS, Hancox JC. Troubleshooting problems with in vitro screening of drugs for QT interval prolongation using HERG K+ channels expressed in mammalian cell lines and Xenopus oocytes. J Pharmacol Toxicol Methods. 2002; 48: 65–80.[CrossRef][Medline] [Order article via Infotrieve]
  16. Madeja M, Musshoff U, Speckmann EJ. Follicular tissues reduce drug effects on ion channels in oocytes of Xenopus laevis. Eur J Neurosci. 1997; 9: 599–604.[CrossRef][Medline] [Order article via Infotrieve]
  17. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004; 79: 727–747.[Abstract/Free Full Text]
  18. Erlund I, Meririnne E, Alfthan G, Aro A. Plasma kinetics and urinary excretion of the flavonones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J Nutr. 2001; 131: 235–241.[Abstract/Free Full Text]
  19. Karle C, Thomas D, Kiehn J. The antiarrhythmic drug BRL-32872. Cardiovasc Drug Rev. 2002; 20: 111–120.[Medline] [Order article via Infotrieve]

Related Article:

Issue Highlights
Circulation 2005 111: 829. [Full Text]



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
W. Zhang, E. Zitron, M. Homme, L. Kihm, C. Morath, D. Scherer, S. Hegge, D. Thomas, C. P. Schmitt, M. Zeier, et al.
Aquaporin-1 Channel Function Is Positively Regulated by Protein Kinase C
J. Biol. Chem., July 20, 2007; 282(29): 20933 - 20940.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Cogolludo, G. Frazziano, A. M. Briones, L. Cobeno, L. Moreno, F. Lodi, M. Salaices, J. Tamargo, and F. Perez-Vizcaino
The dietary flavonoid quercetin activates BKCa currents in coronary arteries via production of H2O2. Role in vasodilatation
Cardiovasc Res, January 15, 2007; 73(2): 424 - 431.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
111/7/835    most recent
01.CIR.0000155617.54749.09v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zitron, E.
Right arrow Articles by Karle, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zitron, E.
Right arrow Articles by Karle, C. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Cardiovascular Pharmacology
Right arrow Primary prevention
Right arrow Arrythmias-basic studies
Right arrowRelated Article